Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

A transgenic mouse model of the ubiquitin/proteasome system.

Impairment of the ubiquitin/proteasome system has been proposed to play a role in neurodegenerative disorders such as Alzheimer and Parkinson diseases. Although recent studies confirmed that some disease-related proteins block proteasomal degradation, and despite the existence of excellent animal models of both diseases, in vivo data about the system are lacking. We have developed a model for in vivo analysis of the ubiquitin/proteasome system by generating mouse strains transgenic for a green fluorescent protein (GFP) reporter carrying a constitutively active degradation signal. Administration of proteasome inhibitors to the transgenic animals resulted in a substantial accumulation of GFP in multiple tissues, confirming the in vivo functionality of the reporter. Moreover, accumulation of the reporter was induced in primary neurons by UBB+1, an aberrant ubiquitin found in Alzheimer disease. These transgenic animals provide a tool for monitoring the status of the ubiquitin/proteasome system in physiologic or pathologic conditions.

Pubmed ID: 12872133


  • Lindsten K
  • Menéndez-Benito V
  • Masucci MG
  • Dantuma NP


Nature biotechnology

Publication Data

August 1, 2003

Associated Grants


Mesh Terms

  • Alzheimer Disease
  • Animals
  • Boronic Acids
  • Cells, Cultured
  • Cysteine Endopeptidases
  • Fibroblasts
  • Leupeptins
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Microscopy, Fluorescence
  • Models, Animal
  • Multienzyme Complexes
  • Myocytes, Cardiac
  • Neurodegenerative Diseases
  • Neurons
  • Oligopeptides
  • Organ Specificity
  • Parkinson Disease
  • Proteasome Endopeptidase Complex
  • Recombinant Fusion Proteins
  • Tissue Distribution
  • Ubiquitin